Image1\ 3rd image


DEVON MEDICAL - (FDA) 510(k) approval

Written by Administrator Thursday, 14 April 2011 14:15

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)-- Devon Medical Products, a manufacturer and distributor of creative, safe, and cost-effective medical devices, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its ArterioFlow™ 7500 arterial pump that treats diabetic foot ulcers, peripheral arterial disease, and other chronic disorders of the lower extremities caused by reduced blood supply or ischemia. Devon Medical Products will feature the ArterioFlow 7500 and its line of CircuFlow™ compression pumps that treat lymphedema at the Medtrade Spring Conference at the Sands Expo and Convention Center in Las Vegas on April 13-14.




Cephalon Buys Teva

Written by Administrator Thursday, 14 April 2011 14:12

 Here's a great article that I found on

With Cephalon Buy, Teva Bets on Brand Drugs and More In-House Innovation

If commodity generics and in-licensing deals are all the rage, then Teva just strapped on a fanny pack with its $6.8 billion acquisition of Cephalon.

The deal is expected to skyrocket Teva’s brand drug portfolio to $7 billion in annual sales, making Teva “not only the world’s largest generics company, but also one of the world’s largest specialty pharma companies,” said Shlomo Yanai, Teva’s CEO, on a conference call yesterday. Post-acquisition, the combined entity boasts “more than 30 products in the late stage, and three awaiting filing,” said Yanai.